Department of Bioengineering and Therapeutic Sciences

New NIH funding awarded to the Department of Bioengineering and Therapeutic Sciences in 2011

Fri Apr 13, 2012
New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included a half-dozen on-going projects by BTS faculty:

UCSF School of Pharmacy’s 32nd year of top NIH funding includes many new projects

Fri Apr 13, 2012
chart

School of Pharmacy NIH funding by fiscal year in millions (see below for full chart)

For the 32nd consecutive year, the UCSF School of Pharmacy received more research funding from the National Institutes of Health (NIH) than any other pharmacy school in the United States.

Desai receives Dawson Biotechnology Award

Thu Apr 12, 2012
Desai
© majedphoto.com

Tejal Desai, PhD

UCSF bioengineer Tejal Desai, PhD, will receive the 2012 Paul R. Dawson Biotechnology Award from the American Association of Colleges of Pharmacy (AACP) at the group’s annual meeting in July.

Artificial kidney project led by Roy chosen for accelerated FDA program

Mon Apr 9, 2012
Roy
© majedphoto.com

Shuvo Roy, PhD with a model of the device

The effort led by UCSF bioengineer Shuvo Roy, PhD, to create an implantable artificial kidney for dialysis patients has been selected as one of the first projects to undergo more timely and collaborative review at the U.S. Food and Drug Administration (FDA).

Shoichet is the new director of the QB3 at UCSF

Tue Apr 3, 2012
Shoichet

Brian Shoichet, PhD

Computational chemist Brian Shoichet, PhD, a faculty member in the Department of Pharmaceutical Chemistry, UCSF School of Pharmacy, is the new director of the California Institute for Quantitative Biosciences

UCSF School of Pharmacy tops U.S. News survey list

Tue Mar 13, 2012
students in classroom
The UCSF School of Pharmacy continues to rank number 1 among Doctor of Pharmacy (PharmD) programs in the United States, according to a new, 2012 survey published by U.S. News & World Report.

Update from the Dean - Fall/Winter 2012

Thu Mar 1, 2012
Koda-Kimble
© majedphoto.com

Mary Anne Koda-Kimble, PharmD

Research: growth over past decade from $17.6 to 43.5 million, Apollonio, Roy, Wells, Center for Quantitative Pharmacology, Quantitative Biosciences Consortium. Faculty: DeGrado, Savic, James, Day, Rice, MacDougall, Fischbach, Huang. Students: Hluhanich, Frear, Gavrilova, Gayle, Tantipinichwong,...

Colleagues respond to Dean Koda-Kimble’s retirement announcement

Tue Jan 24, 2012
Koda-Kimble
© majedphoto.com

Mary Anne Koda-Kimble

Following the UCSF website's announcement of School of Pharmacy Dean Mary Anne Koda-Kimble's June 30, 2012 retirement came

Dean Koda-Kimble announces retirement

Tue Jan 10, 2012
UCSF School of Pharmacy Dean Mary Anne Koda-Kimble, PharmD, announced today that she is stepping down as dean and retiring from UCSF on June 30, 2012, after 14 years as dean and 41 years as a member of the faculty.

Computer models to predict drug clearance by liver cells show promise

Tue Nov 22, 2011
schematic diagram

A schematic diagram of the mechanisms built into each cell in the in silico hepatocyte cultures. Checkmarks indicate events affected by the physical and chemical properties of a specific virtual drug object. For example, depending on such properties a given drug bound to an enzyme can have a different probability of being metabolized or released. (Source: Drug Metab Dispos. 2011 Oct;39(10):p. 1910-20)

A holy grail of drug discovery is to answer key questions about potential new drugs less by experiments in petri dishes and lab animals and more by faster, cheaper engineering efforts using predictive computer models.

Pages